Literature DB >> 25458667

Association between probiotics and enteral nutrition in an experimental acute pancreatitis model in rats.

Mark C van Baal1, Michiel J van Rens2, Christopher B Geven2, Francien M van de Pol3, Ilona W van den Brink3, Gerjon Hannink2, Iris D Nagtegaal4, Wilbert H Peters5, Ger T Rijkers2, Hein G Gooszen6.   

Abstract

BACKGROUND/
OBJECTIVES: Recently, a randomized controlled trial showed that probiotic prophylaxis was associated with an increased mortality in enterally fed patients with predicted severe pancreatitis. In a rat model for acute pancreatitis, we investigated whether an association between probiotic prophylaxis and enteral nutrition contributed to the higher mortality rate.
METHODS: Male Sprague-Dawley rats were allocated to four groups: 1) acute pancreatitis (n = 9), 2) acute pancreatitis and probiotic prophylaxis (n = 10), 3) acute pancreatitis and enteral nutrition (n = 10), and 4) acute pancreatitis, probiotic prophylaxis and enteral nutrition (n = 11). Acute pancreatitis was induced by intraductal glycodeoxycholate and intravenous cerulein infusion. Enteral nutrition, saline, probiotics and placebo were administered through a permanent jejunal feeding. Probiotics or placebo were administered starting 4 days before induction of pancreatitis and enteral nutrition 1 day before start until the end of the experiment, 6 days after induction of pancreatitis. Tissue samples and body fluids were collected for microbiological and histological examination.
RESULTS: In all animals, serum amylase was increased six hours after induction of pancreatitis. After fulfilling the experiment, no differences between groups were found in histological severity of pancreatitis, degree of discomfort, weight loss, histological examination of small bowel and bacterial translocation (all p > 0.05). Overall mortality was 10% without differences between groups (p = 0.54).
CONCLUSION: No negative association was found between prophylactic probiotics and enteral nutrition in acute pancreatitis. No new clues for a potential mechanism responsible for the higher mortality and bowel ischaemia in the PROPATRIA study were found.
Copyright © 2014 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Bacterial translocation; Bowel ischaemia; Enteral nutrition; Probiotics; Prophylaxis

Mesh:

Substances:

Year:  2014        PMID: 25458667     DOI: 10.1016/j.pan.2014.10.002

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

Review 1.  Probiotics, their prophylactic and therapeutic applications in human health development: A review of the literature.

Authors:  Bantayehu Addis Tegegne; Bekalu Kebede
Journal:  Heliyon       Date:  2022-06-22

2.  A reassessment of the PROPATRIA study and its implications for probiotic therapy.

Authors:  Ger P A Bongaerts; René S V M Severijnen
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

Review 3.  Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target.

Authors:  Tao Zhang; Guangqi Gao; Hafiz Arbab Sakandar; Lai-Yu Kwok; Zhihong Sun
Journal:  Front Nutr       Date:  2022-02-15

4.  Supplemented Use of Pre-, Pro-, and Synbiotics in Severe Acute Pancreatitis: An Updated Systematic Review and Meta-Analysis of 13 Randomized Controlled Trials.

Authors:  Xu Tian; Yuan-Ping Pi; Xiao-Ling Liu; Hui Chen; Wei-Qing Chen
Journal:  Front Pharmacol       Date:  2018-06-28       Impact factor: 5.810

Review 5.  Microbiota in Pancreatic Diseases: A Review of the Literature.

Authors:  Tommaso Schepis; Sara S De Lucia; Enrico C Nista; Vittoria Manilla; Giulia Pignataro; Veronica Ojetti; Andrea Piccioni; Antonio Gasbarrini; Francesco Franceschi; Marcello Candelli
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.